TY - JOUR
T1 - Extracellular matrix-Induced gene expression in human breast cancer cells
AU - Garamszegi, Nandor
AU - Garamszegi, Susanna P.
AU - Shehadeh, Lina A.
AU - Scully, Sean P.
N1 - Copyright:
Copyright 2012 Elsevier B.V., All rights reserved.
PY - 2009/3/1
Y1 - 2009/3/1
N2 - Extracellular matrix (ECM) molecules modify gene expression through attachment-dependent (focal adhesion-related) integrin receptor signaling. It was previously unknown whether the same molecules acting as soluble peptides could generate signal cascades without the associated mechanical anchoring, a condition that may be encountered during matrix remodeling and degradation and relevant to invasion and metastatic processes. In the current study, the role of ECM ligand-regulated gene expression through this attachment-independent process was examined. It was observed that fibronectin, laminin, and collagen type I and II induce Smad2 activation in MCF-10A and MCF-7 cells. This activation is not caused by transforming growth factor (TGF)-β ligand contamination or autocrine TGF involvement and is 3- to 5-fold less robust than the TGF-pl ligand. The resulting nuclear translocation of Smad4 in response to ECM ligand indicates downstream transcriptional responses occurring. Coimmunoprecipitation experiments determined that collagen type II and laminin act through interaction with integrin α 2β 1 receptor complex. The ECM ligand-induced Smad activation (termed signaling crosstalk) resulted in cell type and ligand-specific transcriptional changes, which are distinct from the TGF- i ligand-induced responses. These findings show that cell-matrix communication is more complex than previously thought. Soluble ECM peptides drive transcriptional regulation through corresponding adhesion and non-attachment-related processes. The resultant gene expressional patterns correlate with pathway activity and not by the extent of Smad activation. These results extend the complexity and the existing paradigms of ECM-cell communication to ECM ligand regulation without the necessity of mechanical coupling.
AB - Extracellular matrix (ECM) molecules modify gene expression through attachment-dependent (focal adhesion-related) integrin receptor signaling. It was previously unknown whether the same molecules acting as soluble peptides could generate signal cascades without the associated mechanical anchoring, a condition that may be encountered during matrix remodeling and degradation and relevant to invasion and metastatic processes. In the current study, the role of ECM ligand-regulated gene expression through this attachment-independent process was examined. It was observed that fibronectin, laminin, and collagen type I and II induce Smad2 activation in MCF-10A and MCF-7 cells. This activation is not caused by transforming growth factor (TGF)-β ligand contamination or autocrine TGF involvement and is 3- to 5-fold less robust than the TGF-pl ligand. The resulting nuclear translocation of Smad4 in response to ECM ligand indicates downstream transcriptional responses occurring. Coimmunoprecipitation experiments determined that collagen type II and laminin act through interaction with integrin α 2β 1 receptor complex. The ECM ligand-induced Smad activation (termed signaling crosstalk) resulted in cell type and ligand-specific transcriptional changes, which are distinct from the TGF- i ligand-induced responses. These findings show that cell-matrix communication is more complex than previously thought. Soluble ECM peptides drive transcriptional regulation through corresponding adhesion and non-attachment-related processes. The resultant gene expressional patterns correlate with pathway activity and not by the extent of Smad activation. These results extend the complexity and the existing paradigms of ECM-cell communication to ECM ligand regulation without the necessity of mechanical coupling.
UR - http://www.scopus.com/inward/record.url?scp=62549136078&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=62549136078&partnerID=8YFLogxK
U2 - 10.1158/1541-7786.MCR-08-0227
DO - 10.1158/1541-7786.MCR-08-0227
M3 - Article
C2 - 19276183
AN - SCOPUS:62549136078
VL - 7
SP - 319
EP - 329
JO - Molecular Cancer Research
JF - Molecular Cancer Research
SN - 1541-7786
IS - 3
ER -